No data to show
XHKG
2373
Market cap711mUSD
Jun 13, Last price
23.70HKD
1D
3.49%
1Q
30.65%
IPO
-18.28%
Name
Beauty Farm Medical & Health Industry Inc
Chart & Performance
P/E
22.38
P/S
1.99
EPS
0.97
Div Yield, %
1.98%
Shrs. gr., 5y
-0.07%
Rev. gr., 5y
12.86%
Revenues
2.57b
+19.91%
Net income
228m
+5.94%
CFO
797m
+27.36%
Dividend
Aug 19, 20250.52 HKD/sh
Profile
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, such as energy-based services and injection services, as well as surgical aesthetic medical services; and subhealth assessment and intervention services. As of June 30, 2022, the company operated 352 stores, including 177 direct stores and 175 franchised stores under the BeautyFarm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 2,572,199 19.91% | 2,145,068 31.16% | 1,635,414 -8.16% | |||
Cost of revenue | 2,268,073 | 1,368,890 | 1,119,876 | |||
Unusual Expense (Income) | ||||||
NOPBT | 304,126 | 776,178 | 515,538 | |||
NOPBT Margin | 11.82% | 36.18% | 31.52% | |||
Operating Taxes | 65,405 | 58,130 | 19,943 | |||
Tax Rate | 21.51% | 7.49% | 3.87% | |||
NOPAT | 238,721 | 718,048 | 495,595 | |||
Net income | 228,460 5.94% | 215,657 109.15% | 103,109 -46.71% | |||
Dividends | (86,999) | (204,263) | ||||
Dividend yield | 3.41% | |||||
Proceeds from repurchase of equity | 506,545 | 3,976 | ||||
BB yield | -19.87% | |||||
| Debt | ||||||
Debt current | 240,175 | 169,343 | 150,979 | |||
Long-term debt | 1,071,235 | 956,897 | 900,025 | |||
Deferred revenue | (8,647) | |||||
Other long-term liabilities | 71,963 | 8,647 | ||||
Net debt | (526,959) | (63,305) | 886,837 | |||
| Cash flow | ||||||
Cash from operating activities | 796,627 | 625,510 | 382,000 | |||
CAPEX | (159,237) | (140,789) | ||||
Cash from investing activities | (340,851) | (711,185) | 53,626 | |||
Cash from financing activities | (223,363) | 133,741 | (432,820) | |||
FCF | 476,027 | 107,563 | 547,427 | |||
| Balance | ||||||
Cash | 1,830,778 | 1,574,179 | 910,630 | |||
Long term investments | 7,591 | (384,634) | (746,463) | |||
Excess cash | 1,709,759 | 1,082,292 | 82,396 | |||
Stockholders' equity | 615,438 | 373,280 | 118,751 | |||
Invested Capital | 1,162,357 | 1,024,073 | 514,884 | |||
ROIC | 21.84% | 93.32% | 83.11% | |||
ROCE | 17.11% | 54.69% | 85.08% | |||
| EV | ||||||
Common stock shares outstanding | 229,753 | 230,086 | 230,581 | |||
Price | 17.80 60.65% | 11.08 | ||||
Market cap | 4,089,603 60.42% | 2,549,353 | ||||
EV | 3,593,248 | 2,518,385 | ||||
EBITDA | 304,126 | 1,107,914 | 812,779 | |||
EV/EBITDA | 11.81 | 2.27 | ||||
Interest | 24,811 | 24,713 | ||||
Interest/NOPBT | 3.20% | 4.79% | ||||